Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
05/2005
05/17/2005US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus
05/17/2005US6894052 Serotonergic receptor antagonist
05/17/2005US6894051 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
05/17/2005US6893716 Non-covalent assembly of multilayer thin film supramolecular structures
05/17/2005US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine
05/17/2005US6893471 For dyeing human hair
05/17/2005CA2103845C 9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines
05/12/2005WO2005043124A2 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors
05/12/2005WO2005042550A1 Metal complexes with bipodal ligands
05/12/2005WO2005042524A1 Pyridine carboxamide and methods for inhibiting hiv integrase
05/12/2005WO2005042516A2 Ligands of melanocortin receptors and compositions and methods related thereto
05/12/2005WO2005042515A1 Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethylbenzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
05/12/2005WO2005042513A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
05/12/2005WO2005042498A2 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
05/12/2005WO2005042494A1 Isopentyl carboxanilides for combating undesired micro-organisms
05/12/2005WO2005042493A1 Hexyl carboxanilides and their use for controlling undesirable micro-organisms
05/12/2005WO2005042492A1 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms
05/12/2005WO2005042488A1 Pyridine compounds as inhibitors of dipeptidyl peptidase iv
05/12/2005WO2005042475A2 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
05/12/2005WO2005042464A1 Androgen receptor modulators
05/12/2005WO2005042460A1 Production process of optically pure 2- (4-hydroxyphenoxy) - propionic acid compounds
05/12/2005WO2005042444A2 Platinum complex and luminescent element
05/12/2005WO2005041959A1 Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists
05/12/2005WO2005023765A8 Method for catalyzing amidation reactions by the presence of co2
05/12/2005WO2005021490A3 N-SULFONYL-α-AMINO-ACID DERIVATIVES
05/12/2005WO2004113341A3 Fungicidal triazolopyrimidines
05/12/2005WO2004092145A8 Alpha substituted carboxylic acid as ppar modulators
05/12/2005WO2004072087A3 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
05/12/2005WO2004022775A8 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use
05/12/2005WO2003006454A8 Heterocyclic carboxamides and their use as fungicides
05/12/2005US20050101798 C2-substituted idan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals
05/12/2005US20050101783 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide
05/12/2005US20050101671 Compounds and compositions for delivering active agents
05/12/2005US20050101646 Tyrosine kinase inhibitor; antiproliferative agents; controlling signal transduction; anticancer agents
05/12/2005US20050101644 Benzylether amine compounds useful as CCR-5 antagonists
05/12/2005US20050101642 Niacinamide derivatives as inhibitor of poly(ADP-ribose)polymerase; ranitidine, cimetidine, famotidine, nizatidine as gastric acid secretion control; immunomodulation and suppression of hypersensitivity and inflammatory reaction; IgE mediated allergic reaction; no side effects; virtually non-toxic
05/12/2005US20050101634 Bis(5-aeyl-2-pyridyl) derivatives
05/12/2005US20050101626 Imidazo-fused oxazolo[4,5-beta]pyridine and imidazo-fused thiazolo[4,5-beta]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
05/12/2005US20050101613 Substituted pyrimidine derivatives
05/12/2005US20050101590 Cannabinoid receptor agonists
05/12/2005US20050101521 Bind as ligands to human peroxisome proliferator activated receptor to activate receptor and thereby exhibit potent effects of decreasing neutral fat, cholesterol, and blood sugar; for example, 2-[[4-ethoxy-3-[[[4-(2-pyridyloxy)phenyl]carbonylamino]methyl]phenyl]methyl]butyric acid; diabetes treatment
05/12/2005US20050100614 Chromium bound to niacin and three compounds from the group consisting of (-) hydroxycitric acid, zinc (particularly zinc methionine), trans-reseveratrol, gymnernic acid, selenium, an anthocyanidin, allicin, and fenugreek.
05/12/2005US20050100511 Photoactive layer containing a lanthanide complex selected from [Ln( beta -enolate)3(phosphine oxide-pyridine N-oxide) derivatives
05/12/2005US20050099209 Circuit element having a first layer composed of an electrically insulating substrate material, a method for producing a circuit element, bispyridinium compounds and their use in circuit elements
05/12/2005CA2544317A1 Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists
05/12/2005CA2543529A1 Pyridine compounds as inhibitors of dipeptidyl peptidase iv
05/12/2005CA2543345A1 Androgen receptor modulators
05/12/2005CA2543322A1 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
05/12/2005CA2543054A1 Isopentylcarboxanilides for combating undesired micro-organisms
05/12/2005CA2540843A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
05/12/2005CA2540342A1 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
05/12/2005CA2535036A1 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
05/11/2005EP1529530A1 Compounds affecting glucokinase
05/11/2005EP1529240A2 Electrolytes for electrooptic devices comprising ionic liquids
05/11/2005EP1529037A2 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
05/11/2005EP1529031A1 Acylated arylcycloalkylamines and their use as pharmaceuticals
05/11/2005EP1417172A4 Process for the preparation of amorphous form of torsemide
05/11/2005EP0951464B1 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
05/11/2005CN1615343A Yellow cationic dyes for dying of organic material
05/11/2005CN1615301A Dithiocarbamate derivatives and their use as antibacterial agents
05/11/2005CN1615296A Carboxamidine derivatives and their use in the treatment of vascular diseases
05/11/2005CN1615295A Compounds for treatment of inflammation, diabetes and related disorders
05/11/2005CN1613849A Preparation of 2-Cl-5-F-nicotinate and nicotonic acid
05/11/2005CN1613848A Synthesis of donepizin and its derivative
05/11/2005CN1200703C Use of pentanoate derivant
05/11/2005CN1200702C Use of NMDA antagonist for treatment of irritable bowel syndrome
05/11/2005CN1200673C Antimicotic nail varnish composition
05/10/2005US6890956 Cyclohexyl sulphones as gamma-secretase inhibitors
05/10/2005US6890943 3-acylated pyridoxal derivatives used to treat vitamin B6 deficiency, cardiovascular diseases, melanoma and other related diseases
05/10/2005US6890942 Acyl sulfonamides as inhibitors of HIV integrase
05/10/2005US6890940 Immoglobulin E (IgE) antibody production inhibitor; treating allergic immune diseases such as asthma, dermatitis, inflammatory bowel disease and allergic opthalmopathy
05/10/2005US6890935 Pharmaceutical compositions and methods for use
05/10/2005US6890932 Anthranilic acid derivative
05/10/2005US6890931 Methods of treating disorders with group I mGluR antagonists
05/10/2005US6890885 Herbicidal composition
05/06/2005WO2005040355A2 Tao kinase modulators and methods of use
05/06/2005WO2005040138A1 Substituted benzylaminoalkylene heterocycles
05/06/2005WO2005040136A1 Piperazine derivatives and their use as modulators of nuclear hormone receptor function
05/06/2005WO2005040127A1 Novel compounds as agonist for ppar gamma and ppar alpha, method for preparation of the same, and pharmaceutical composition containing the same
05/06/2005WO2005040122A1 Novel pyrithione complex compound, process for producing the same and use thereof
05/06/2005WO2005040121A2 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor
05/06/2005WO2005040103A1 Medicinal compounds
05/06/2005WO2005040101A1 Acylurea connected and sulfonylurea connected hydroxamates
05/06/2005WO2005040100A1 Tetrahydro-naphthalene and urea derivatives
05/06/2005WO2005040095A1 Inhibitors of dipeptidyl peptidase iv
05/06/2005WO2005030753A3 Therapeutic agents useful for treating pain
05/06/2005WO2005019240A3 Melanin concentrating hormone receptor antagonists
05/06/2005WO2005011656A3 Pyridyl derivatives and their use as therapeutic agents
05/06/2005WO2004113394A3 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom
05/06/2005WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
05/06/2005WO2004043928A8 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
05/06/2005WO2004002939A3 Aminoalcohol derivatives
05/06/2005WO2003068746A8 Aryl ureas as kinase inhibitors
05/06/2005CA2543570A1 Acylurea connected and sulfonylurea connected hydroxamates
05/06/2005CA2542695A1 Substituted benzylaminoalkylene heterocycles
05/06/2005CA2542494A1 Tetrahydro-naphthalene and urea derivatives
05/06/2005CA2542064A1 Tao kinase modulators and methods of use
05/06/2005CA2541989A1 P70s6 kinase modulators and method of use
05/06/2005CA2539967A1 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor
05/06/2005CA2538134A1 Novel imidazole derivatives and their use as pharmaceutical agents
1 ... 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 ... 633